Market Overview

First Solar, Intermolecular Extend, Expand Licensing Deal

Share:
Related IMI
Mid-Afternoon Market Update: Celator Pharmaceuticals Surges On Phase 3 Trial Results For Vyxeos; Constellium Shares Slide
Morgan Stanley Reacts To Intermolecular CEO Transition
Related FSLR
What Role Will Nuclear Play In The Future Of U.S. Energy?
Sectors and Stocks To Watch If Hillary Clinton Is Elected
The Vetr community has upgraded $FSLR to 3.5-Stars. (Vetr)

Intermolecular, Inc. (Nasdaq: IMI) and First Solar, Inc. (Nasdaq: FSLR) today announced they have entered into a two-year collaboration and licensing agreement focused on further increases to the conversion efficiency of First Solar's cadmium telluride (CdTe) solar cell technology. Under the new collaborative development program, First Solar and Intermolecular researchers will work together to develop disruptive new approaches to increasing the performance of CdTe solar cell technology using Intermolecular's proprietary High Productivity Combinatorial (HPC™) platform. The program targets substantial gains in First Solar's module conversion efficiency beyond its previously announced roadmap.

Posted-In: News

 

Related Articles (FSLR + IMI)

View Comments and Join the Discussion!